These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4454492)

  • 21. [The immunotropic properties of rifampicin and their correction].
    Sakaeva DD; Lazareva DN
    Eksp Klin Farmakol; 1998; 61(2):45-7. PubMed ID: 9621174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the anti-allergic effect of cyclophosphamide in animals sensitized with dead tuberculosis bacilli].
    Arima J; Maeda K; Yamamoto K; Takahashi Y
    C R Seances Soc Biol Fil; 1969; 163(1):249-52. PubMed ID: 4241421
    [No Abstract]   [Full Text] [Related]  

  • 23. A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3.
    Taylor DO; Bristow MR; O'Connell JB; Ensley RD; Olsen SL; Hammond EH; Wagoner LE; Renlund DG
    Transplantation; 1994 Sep; 58(6):645-9. PubMed ID: 7940682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats.
    Paterson PY; Hanson MA
    J Immunol; 1969 Oct; 103(4):795-803. PubMed ID: 5349735
    [No Abstract]   [Full Text] [Related]  

  • 25. [Azathioprine action on production of circulating 19S- and 7S- immunoglobulins in rabbits and mice].
    Burkin AA; Kovalev IE; Sergeev PV
    Farmakol Toksikol; 1970; 33(4):485-8. PubMed ID: 5535799
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of route of antigen administration on the induction of delayed skin reactivity and antibody in rats.
    Chaparas SD; Bowser RT
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):645-53. PubMed ID: 4556140
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunity during ampicillin administration against a background of immunosuppression].
    Sakaeva DD; Lazareva DN
    Eksp Klin Farmakol; 1998; 61(6):39-41. PubMed ID: 9929815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of several immunoactive agents on the course of kidney tuberculosis].
    Bellendir EN; Nakonechnyĭ GD; Peschanskaia IN; Salmagambetov IU
    Probl Tuberk; 1976 Dec; (12):65-9. PubMed ID: 1005407
    [No Abstract]   [Full Text] [Related]  

  • 30. Modification of the immunologic response. I. The effect of streptomycin on the humoral immunologic response in guinea pigs and mice.
    Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1974; 22(3):277-87. PubMed ID: 4600218
    [No Abstract]   [Full Text] [Related]  

  • 31. [Depression of the primary immunity reaction by 6-mercaptopurine and cyclophosphamide in various animal species. II. Different effect of 6-mercaptopurine and cyclophosphamide on the antibody formation of rabbits, guinea pigs, rats, and mice].
    Finger H
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(2):105-20. PubMed ID: 5584703
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative study of the action of cyclophosphamide and procarbazine on the antibody production in mice.
    Liske R
    Clin Exp Immunol; 1973 Oct; 15(2):271-80. PubMed ID: 4762019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of immunosuppressive agents and cytostatics on connective tissue metabolism and antibody production].
    Wirth W; Müller US; Thöne F; Junge-Hülsing G
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:378-81. PubMed ID: 5051960
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
    Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological reactivity to sheep red blood cells in three congenic resistant strains of mice.
    Sabolovic D; Oth D; Burg C
    Immunology; 1971 Mar; 20(3):341-4. PubMed ID: 4927930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of cyclophosphamide on the delayed hypersensitivity in the mouse after intraperitoneal immunization.
    Kerckhaert JA
    Ann Immunol (Paris); 1974 Jun; 125 C(4):559-68. PubMed ID: 4548829
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytotoxic drugs in primary glomerular disease.
    Glassock RJ
    Proc Clin Dial Transplant Forum; 1974; (4):83-5. PubMed ID: 4468427
    [No Abstract]   [Full Text] [Related]  

  • 40. The immune response to heterologous red cells in mice. IV. Induction of unresponsiveness to weakly immunogenic red cells by cyclophosphamide and cortisone acetate.
    Dietrich FM; Dukor P
    Clin Exp Immunol; 1968 Oct; 3(8):783-93. PubMed ID: 5718502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.